By Kiran Mazumdar-Shaw In the face of the biggest health calamity faced by humanity in a century, India’s Bioeconomy grew over 12% to reach $70.2 billion in 2020. The biotech industry braved the challenges of Covid-19 to develop innovative solutions such as diagnostics, therapies and vaccines at speed and scale to save countless lives. India … Continue reading $150-Billion Bioeconomy by 2025: Policy Prescriptions for Building a Vibrant Biotech Sector
From Brewing to Biologics: Kiran Mazumdar-Shaw in conversation with Catherine Jewell, Communications Division, WIPO
Kiran Mazumdar-Shaw shares with Catherine Jewell, her story of innovation and entrepreneurship; Her journey from brewing to creating Biocon, Asia's leading Biopharmaceutical Company.